[1]
Popov, T. et al. 2025. Serum levels of semaphorin 4C in breast cancer – assessment of prognostic value and potential for monitoring surgical treatment response. Acta Medica Bulgarica. 51, 4 (Mar. 2025), 1–7. DOI:https://doi.org/10.2478/AMB-2024-0070.